Anti-USP30 monoclonal antibody

Pre-made anti-USP30 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to USP30/USP30 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0037-Ab-1/ GM-Tg-hg-IP0037-Ab-2Anti-Human USP30 monoclonal antibodyHuman
GM-Tg-rg-IP0037-Ab-1/ GM-Tg-rg-IP0037-Ab-2Anti-Rat USP30 monoclonal antibodyRat
GM-Tg-mg-IP0037-Ab-1/ GM-Tg-mg-IP0037-Ab-2Anti-Mouse USP30 monoclonal antibodyMouse
GM-Tg-cynog-IP0037-Ab-1/ GM-Tg-cynog-IP0037-Ab-2Anti-Cynomolgus/ Rhesus macaque USP30 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0037-Ab-1/ GM-Tg-felg-IP0037-Ab-2Anti-Feline USP30 monoclonal antibodyFeline
GM-Tg-cang-IP0037-Ab-1/ GM-Tg-cang-IP0037-Ab-2Anti-Canine USP30 monoclonal antibodyCanine
GM-Tg-bovg-IP0037-Ab-1/ GM-Tg-bovg-IP0037-Ab-2Anti-Bovine USP30 monoclonal antibodyBovine
GM-Tg-equg-IP0037-Ab-1/ GM-Tg-equg-IP0037-Ab-2Anti-Equine USP30 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0037-Ab-1/ GM-Tg-hg-IP0037-Ab-2; GM-Tg-rg-IP0037-Ab-1/ GM-Tg-rg-IP0037-Ab-2;
GM-Tg-mg-IP0037-Ab-1/ GM-Tg-mg-IP0037-Ab-2; GM-Tg-cynog-IP0037-Ab-1/ GM-Tg-cynog-IP0037-Ab-2;
GM-Tg-felg-IP0037-Ab-1/ GM-Tg-felg-IP0037-Ab-2; GM-Tg-cang-IP0037-Ab-1/ GM-Tg-cang-IP0037-Ab-2;
GM-Tg-bovg-IP0037-Ab-1/ GM-Tg-bovg-IP0037-Ab-2; GM-Tg-equg-IP0037-Ab-1/ GM-Tg-equg-IP0037-Ab-2
Products NameAnti-USP30 monoclonal antibody
Formatmab
Target NameUSP30
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-USP30 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0037-Ag-1Recombinant multi-species UBP30/ USP30 protein


    Target information

    Target IDGM-IP0037
    Target NameUSP30
    Gene ID84749,100756,304579,706607,611662,101087177,100140210,100066762
    Gene Symbol and Synonyms6330590F17Rik,D5Ertd483e,USP30
    Uniprot AccessionQ70CQ3,D3ZPG5
    Uniprot Entry NameUBP30_HUMAN,UBP30_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000135093
    Target ClassificationN/A

    The target: USP30, gene name: USP30, also named as . USP30, a member of the ubiquitin-specific protease family (see USP1, MIM 603478), is a novel mitochondrial deubiquitinating (DUB) enzyme (Nakamura and Hirose, 2008 [PubMed 18287522]).[supplied by OMIM, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.